Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CYP2B6 Antikörper

Es sind 3+ Publikationen für dieses Produkt verfügbar. Der Maus Monoklonal anti-CYP2B6 Antikörper wird verwendet zum Nachweis von CYP2B6 in Proben von Human, Maus, Ratte, Hund und Affe. Er wurde validiert für WB, IHC, IF und FACS.
Produktnummer ABIN2718982
627,08 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 6 bis 8 Werktagen

Kurzübersicht für CYP2B6 Antikörper (ABIN2718982)

Target

Alle CYP2B6 Antikörper anzeigen
CYP2B6 (Cytochrome P450, Family 2, Subfamily B, Polypeptide 6 (CYP2B6))

Reaktivität

  • 61
  • 18
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte, Hund, Affe

Wirt

  • 59
  • 1
  • 1
Maus

Klonalität

  • 60
  • 1
Monoklonal

Konjugat

  • 22
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CYP2B6 Antikörper ist unkonjugiert

Applikation

  • 41
  • 21
  • 18
  • 15
  • 13
  • 13
  • 11
  • 9
  • 3
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Klon

3D5
  • Produktmerkmale

    Homo sapiens cytochrome P450, family 2, subfamily B, polypeptide 6 (CYP2B6)

    Aufreinigung

    Purified from mouse ascites fluids by affinity chromatography

    Immunogen

    Full length human recombinant protein of human CYP2B6(NP_000758) produced in HEK293T cell.

    Isotyp

    IgG2a
  • Applikationshinweise

    WB 1:500~2000, IHC 1:150, IF 1:100, FLOW 1:100,

    Kommentare

    The concentration of the product may vary between diferrent lots.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.5-1.0 mg/mL

    Buffer

    PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C
  • Sim, Nam, Lee, Lee, O, Joo, Liu, Han, Ki, Jeong, Lee, Lee: "Selective induction of hepatic cytochrome P450 2B activity by leelamine in vivo, as a potent novel inducer." in: Archives of pharmacal research, Vol. 38, Issue 5, pp. 725-33, (2015) (PubMed).

    Chai, Feng, Zhang, Chen, Cheng, He, Yang, He, Wang, Wang, Chen: "Hepatic expression of detoxification enzymes is decreased in human obstructive cholestasis due to gallstone biliary obstruction." in: PLoS ONE, Vol. 10, Issue 3, pp. e0120055, (2015) (PubMed).

    Fredman, Li, Dalli, Chiang, Serhan: "Self-limited versus delayed resolution of acute inflammation: temporal regulation of pro-resolving mediators and microRNA." in: Scientific reports, Vol. 2, pp. 639, (2012) (PubMed).

  • Target

    CYP2B6 (Cytochrome P450, Family 2, Subfamily B, Polypeptide 6 (CYP2B6))

    Andere Bezeichnung

    CYP2B6

    Hintergrund

    This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described, however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q.

    Molekulargewicht

    56.1 kDa

    Gen-ID

    1555

    NCBI Accession

    NM_000767

    HGNC

    1555
Sie sind hier:
Chat with us!